Szpital Uniwersytecki Imienia Karola Marcinkowskiego W Zielonej Gorze Sp. z o. o.
- Address
- Ul. Zyty 26, 65-046 Zielona Góra, Poland
Szpital Uniwersytecki Imienia Karola Marcinkowskiego W Zielonej Gorze - Comprehensive Clinical Research Center
This university hospital serves as a multidisciplinary clinical research center conducting advanced trials across cardiovascular medicine, hematologic malignancies, neonatal care, and surgical oncology. The institution demonstrates particular expertise in perioperative medicine and interventional cardiology, contributing to international multicenter studies that advance therapeutic strategies for critically ill patients.
- Cardiovascular research focusing on myocardial infarction recovery, iron deficiency management, and perioperative cardiac protection strategies
- Hematologic oncology trials investigating novel therapies for acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms
- Neonatal medicine studies addressing persistent pulmonary hypertension and respiratory disorders in newborns
- Advanced surgical oncology research including hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric carcinoma
The center's research portfolio spans from early-phase dose-finding studies to large pivotal trials, with emphasis on personalized medicine approaches in oncology and cardiovascular risk reduction in surgical patients. The facility participates in cutting-edge investigations of targeted therapies including menin inhibitors for hematologic malignancies and innovative perioperative interventions to prevent myocardial injury, demonstrating its commitment to translating novel scientific discoveries into improved patient outcomes across multiple medical specialties.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Agencja Badań Medycznych1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ryvu Therapeutics S.A.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Szpital Uniwersytecki Imienia Karola Marcinkowskiego W Zielonej Gorze Sp. z o. o.
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Assessment of Persistent Pulmonary Hypertension Incidence in Neonates with Respiratory Failure Treated with Salbutamol Sulfate and Sodium Chloride | Medical University Of Warsaw | Phase I | Not Recruiting | Nov 2021 | Nov 2025 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride | 2 | Unknown | 2024-01-23 | 2024-09-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.